|
Groups
|
Cutoff
|
Patients
|
3-year OS
|
5-year OS
|
P
|
|---|
|
NLR
| | | |
<0.001
|
|
<3.10
|
732
|
76.50%
|
66.10%
| |
|
>3.10
|
220
|
58.40%
|
48.80%
| |
|
dNLR
| | | |
<0.001
|
|
<0.499
|
262
|
79.50%
|
62.80%
| |
|
>0.499
|
690
|
65.30%
|
53.40%
| |
|
PLR
| | | |
<0.001
|
|
<170.58
|
738
|
75.00%
|
63.00%
| |
|
>170.58
|
214
|
65.70%
|
48.80%
| |
|
LMR
| | | |
<0.001
|
|
<3.53
|
388
|
64.60%
|
77.60%
| |
|
>3.53
|
564
|
54.60%
|
57.20%
| |
|
SII
| | | |
<0.001
|
|
<781.82
|
729
|
75.70%
|
61.00%
| |
|
>781.82
|
233
|
66.90%
|
46.70%
| |
- NLR neutrophil to lymphocyte ratio
- dNLR derived neutrophil to lymphocyte ratio
- PLR platelet to lymphocyte ratio
- LMR lymphocyte to monocyte ratio
- SII systematic immune-inflammation index
